Clinical Trials Browser

Has results × Depression × Escitalopram × Clear all

Depression, Depressive Disorder, Major, Head and Neck Neoplasms

NCT00352885 2018-09-14

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

Phase 4 Completed

20 enrolled 11 charts

Depression, Neoplasms

NCT00621946 2014-02-04

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Phase 4 Completed

26 enrolled 13 charts

Lymphoid

Asthma, Depression, Depressive Disorder, Major, Lymphoma, Follicular

NCT00387348 2012-12-03

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Phase 3 Terminated

24 enrolled 11 charts

GastrointestinalThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Clinical Trials

PROTECT

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer